Cyted is a pioneering brand committed to saving lives by detecting cancer at an early stage. Specializing in novel diagnostic tests, Cyted aims to bring about a revolution in cancer detection. Leveraging advanced sampling technologies and AI-driven biomarkers, they provide clinicians with clinical insights that lead to improved patient outcomes.

With their unique clinical pathway and biomarker data platform, Cyted is poised to transform the patient journey for upper gastrointestinal (GI) disease management. By bringing health services closer to patients in primary care, they reduce the burden on specialist providers and hospitals. Their innovative diagnostic tools for esophageal cancer and upper GI diseases fundamentally change how clinicians make decisions, leading to better diagnostics and outcomes.

Cyted's approach helps healthcare systems reduce costs and unnecessary interventions like endoscopies. Their mission is to build a world where cancer is diagnosed earlier and faster. Based in Cambridge, UK, Cyted is at the forefront of the diagnostic revolution.

Get in touch with them to learn more